18.09.2014 • NewsAkzoNobelPhotanolBiotechnology

AkzoNobel and Photanol to Develop Green Building Blocks

AkzoNobel has teamed up with Dutch biotechnology specialist Photanol to develop a solar power route to green chemistry.

In the partnership designed to be a stepping stone for potential commercial production of fourth generation bio-based chemicals, the companies plan to explore sustainable technology that mimics the way plants use photosynthesis.

Peter Nieuwenhuizen, Akzo Nobel's director of innovation and partnerships, described Photanol's existing CO2 technology as a "potential game changer, saying the company is constantly looking for less traditional solutions with the potential to significantly reduce its carbon footprint.

"Given the challenges the world is facing in terms of resource scarcity, we are actively looking for bio-based alternatives for our chemicals, and Photanol's existing technology is a potential game-changer," Nieuwenhuizen added.

The collaboration will focus on a Photanol process that uses light to directly convert CO2 from the air into selected raw materials such as acetic acid and butanol, with oxygen as the only byproduct.

Michiel Lensink, CEO of Photanol, which had been seeking partnerships with major companies, said the cooperation with the chemical producer is "of major strategic importance" not only because it provides access to a large potential market, but also because tapping the industrial partner's processing technology expertise will shorten the products' time to market.

The partners will start by developing a certain unspecified chemicals currently used by Akzo Nobel's Specialty Chemicals business area.

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.